Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Manuela, Altieri"'
Publikováno v:
Frontiers in Psychiatry, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/3c722ab40cf2447cbaa3a1c96de8d2a1
Autor:
Rocco Capuano, Giovanna Donnarumma, Alvino Bisecco, Elena Grimaldi, Miriana Conte, Alessandro d’Ambrosio, Federica Matrone, Mario Risi, Riccardo Maria Borgo, Manuela Altieri, Federica Giuliano, Nicola Coppola, Massimiliano Galdiero, Gioacchino Tedeschi, Antonio Gallo
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Externí odkaz:
https://doaj.org/article/426065eb7f73412bbd595cd273e555be
The relationship between depression and cognitive performance in multiple sclerosis: a meta-analysis
Publikováno v:
The Clinical Neuropsychologist. :1-21
Objective: Studies on the relationship between depression and cognition on patients with multiple sclerosis (MS) are inconsistent and it is not clear whether higher depression levels are associated with impairment of specific cognitive domains or pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::459cf724d0c56f4eed383f19954ffc93
https://doi.org/10.1080/13854046.2023.2192963
https://doi.org/10.1080/13854046.2023.2192963
Autor:
Alvino Bisecco, Manuela Altieri, Gabriella Santangelo, Federica Di Nardo, Renato Docimo, Giuseppina Caiazzo, Rocco Capuano, Simona Pappacena, Alessandro d’Ambrosio, Simona Bonavita, Francesca Trojsi, Mario Cirillo, Fabrizio Esposito, Gioacchino Tedeschi, Antonio Gallo
Publikováno v:
Frontiers in Behavioral Neuroscience, Vol 13 (2020)
Social cognition includes mental operations essential for functional social interactions, and several studies revealed an impairment of social cognition abilities in patients with Multiple Sclerosis (MS). These deficits have been related to global an
Externí odkaz:
https://doaj.org/article/925b37d9b76344c58085ff2e149c25cc
Autor:
Francesco Sacca, Teresa Costabile, Elisabetta Signoriello, Francesca Lauro, Manuela Altieri, Antonio Rosario Ziello, Alessandro d’Ambrosio, Alvino Bisecco, Giorgia Teresa Maniscalco, Simona Bonavita, Antonio Gallo, Vincenzo Brescia Morra, Giacomo Lus, Cinzia Valeria Russo
Publikováno v:
Sunday, April 23.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c68e7a07f648e24c3ded8505585833c2
https://doi.org/10.1212/wnl.0000000000203450
https://doi.org/10.1212/wnl.0000000000203450
Publikováno v:
Neurological Sciences.
Introduction Evaluation of apathy in non-clinical populations is relevant to identify individuals at risk for developing cognitive decline in later stages of life, and it should be performed with questionnaires specifically designed for healthy indiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da9bc96a8bb795e532cad107617e6a50
https://doi.org/10.1007/s10072-023-06774-0
https://doi.org/10.1007/s10072-023-06774-0
Autor:
Chiara, Marzi, D'Ambrosio, Alessandro, Stefano, Diciotti, Alvino, Bisecco, Manuela, Altieri, Massimo, Filippi, Maria Assunta Rocca, Loredana, Storelli, Pantano, Patrizia, Tommasin, Silvia, Cortese, ROSA MARIA, De Stefano, Nicola, Gioacchino, Tedeschi, Antonio, Gallo, the INNI Network
Many patients with multiple sclerosis (MS) experience information processing speed (IPS) deficits, and the Symbol Digit Modalities Test (SDMT) has been recommended as a valid screening test. Magnetic resonance imaging (MRI) has markedly improved the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::203a91091ad56d188300b9577b8a9f90
https://hdl.handle.net/11365/1223879
https://hdl.handle.net/11365/1223879
Autor:
Manuela Altieri, Rocco Capuano, Miriana Conte, Giovanna Donnarumma, Elena Grimaldi, Nicola Coppola, Massimiliano Galdiero, Alessandro d’Ambrosio, Gioacchino Tedeschi, Antonio Gallo
Publikováno v:
Neurological Sciences. 43:2947-2949
Background: Few studies investigated the immune response to SARS-CoV-2 vaccine in patients with multiple sclerosis (pwMS) treated with natalizumab (NTZ) and found a short-term efficient humoral response; however, there are no studies assessing the le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0de1b5495da065d69e76be66c8ae3e00
https://doi.org/10.1007/s10072-022-05940-0
https://doi.org/10.1007/s10072-022-05940-0
Autor:
Rocco Capuano, Luca Prosperini, Manuela Altieri, Lorena Lorefice, Roberta Fantozzi, Paola Cavalla, Clara Guaschino, Marta Radaelli, Cinzia Cordioli, Viviana Nociti, Laura Boffa, Paolo Ragonese, Maria Di Gregorio, Federica Pinardi, Valentina Torri Clerici, Giovanna De Luca, Alberto Gajofatto, Damiano Paolicelli, Carla Tortorella, Claudio Gasperini, Claudio Solaro, Eleonora Cocco, Alvino Bisecco, Antonio Gallo
Publikováno v:
Multiple Sclerosis Journal. :135245852311675
Background: Little is known about COVID-19 course and outcomes after a third booster dose of mRNA vaccine against SARS-CoV-2 (mRNA-Vax) in patients with multiple sclerosis (pwMS) treated with ocrelizumab (OCR) and fingolimod (FNG), which showed a wea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90b1b3170f72efda0faca61734b112d0
https://doi.org/10.1177/13524585231167515
https://doi.org/10.1177/13524585231167515
Autor:
Rocco Capuano, Alvino Bisecco, Miriana Conte, Giovanna Donnarumma, Manuela Altieri, Elena Grimaldi, Gianluigi Franci, Annalisa Chianese, Massimiliano Galdiero, Nicola Coppola, Gioacchino Tedeschi, Antonio Gallo
Publikováno v:
Multiple sclerosis and related disorders. 60
Real-world clinical data suggest an attenuated short-term humoral response to SARS-CoV-2 vaccines in patients with multiple sclerosis (pwMS) receiving high efficacy (HE) disease modifying therapies (DMTs) such as Ocrelizumab (OCR) and Fingolimod (FNG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d38277d1215ae40796dc42519eec7ac
https://pubmed.ncbi.nlm.nih.gov/35272145
https://pubmed.ncbi.nlm.nih.gov/35272145